Category
Pharmaceuticals
-
•
Consumer group challenges selenium claim
It’s put up or shut up time for Bayer Healthcare. The Center for Science in the Public Interest is threatening…
-
•
GAO review finds fault in FDA’s device oversight
The Government Accountability Office looked into how the FDA oversees medical devices and found that it does not review all…
-
•
First Amendment defense fails InterMune exec
If any company thinks a press release is protected speech under the First Amendment of the U.S. Constitution and, therefore, can’t be used…
-
•
Med school conflict of interest policies rated
The American Medical Student Association released a 2009 version of their PharmFreeScorecard, evaluating 149 U.S. medical schools based on their…
-
Diabetes study ups ante for comparing treatments
Of all the potential reforms to the health-care system, one of the most profound might turn out to be a…
-
•
Tribune: Lupron to treat autism is ‘junk science’
The Chicago Tribune‘s Trine Tsouderos reports on the growing use of Lupron, a drug sometimes used to chemically castrate sex…
-
•
Pharma industry still finding its way in social media
Big pharma continues to dabble, tentatively, with social media. The latest example is GlaxoSmithKline, which this week launched its very own…
-
•
Dental health care disparities overlooked
Guy Boulton of the Milwaukee Journal Sentinel investigates the “lack of access to dental care for children and adults on…
-
•
Hospital cancels ads, bans paper after story
The Hackensack University Medical Center, apparently unhappy about a story about its governing board, has pulled advertising from The (Bergen…
-
•
Students look at rural health care in north Ga.
Students at the University of Georgia spent the past few months assembling a 19-story package on health in six rural…